Table 1.
Antagonists | |||||||
---|---|---|---|---|---|---|---|
0 µM | 1 µM | 3 µM | 10 µM | 30 µM | 100 µM | ||
Yohimbine | EC50 | 0,16 ± 0,03 | 0,508 ± 0,087 | 0,681 ± 0,37 | 1,61 ± 1,2 | 4,11 ± 1,1 | 12,0 ± 5,8 |
nH | 1.11 | 0.93 | 0.96 | 0.87 | 0.89 | 0.96 | |
Max | 6060 ± 1010 | 4306 ± 585 | 6536 ± 150 | 6299 ± 776 | 5151 ± 165 | 5787 ± 660 | |
n | 8 | 3 | 3 | 6 | 4 | 6 | |
ρ-Da1b | EC50 | 0.16 ± 0.03 | 0.173 ± 0.038 | 0.419 ± 0.098 | 0.611 ± 0.48 | 0.745 ± 0.56 | 2.21 ± 0.68 |
nH | 1.11 | 1.04 | 1.01 | 0.89 | 0.92 | 0.81 | |
Max | 6060 ± 1010 | 6766 ± 186 | 6125 ± 762 | 6414 ± 701 | 6680 ± 1243 | 7232 ± 126 | |
n | 8 | 3 | 4 | 6 | 6 | 3 |
n, number of experiments.